← FDA DRUG APPROVALS

FDA ANDA · ANDA200302

CLOBETASOL PROPIONATE

Sponsor: SUN PHARMA CANADA

APPLICATION
ANDA200302
TYPE
ANDA
ORIGINAL APPROVAL
2012-07-02
LATEST ACTION
2019-09-06
ROUTE
TOPICAL
DOSAGE FORM
LOTION
MARKETING STATUS
Prescription

Products

CLOBETASOL PROPIONATEPrescription
CLOBETASOL PROPIONATE 0.05% · LOTION · TOPICAL

Approval history

2019-09-06Labeling · Supplement 2 · standardAP
2012-07-02OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →